Construction and analysis of regulatory genetic networks in cervical cancer based on involved microRNAs, target genes, transcription factors and host genes

Oncology Letters

Volumn 7, Issue 4, 2014, Pages 1279-1283

  Wang, Ning ^a   Xu, Zhiwen ^a   Wang, Kunhao ^a   Zhu, Minghui ^a   Li, Yang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Cervical cancer; Genetic regulation; MicroRNA; Network; Transcription factor

Indexed keywords

MICRORNA; MICRORNA 21; MICRORNA 214; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; DNA SEQUENCE; EXPERIMENTAL DESIGN; GENE; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; HOST GENE; HUMAN; PATHOGENESIS; TARGET GENE; UTERINE CERVIX CANCER;

EID: 84896703100     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1814     Document Type: Article

References (34)

1. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al: Mutations of the BRAF gene in human cancer. Nature 417: 949-954, 2002.
2. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
3. Hamada S, Satoh K, Miura S, Hirota M, Kanno A, et al: miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol 228: 1255-1263, 2013.
4. Nohata N, Hanazawa T, Kinoshita T, Okamoto Y and Seki N: MicroRNAs function as tumor suppressors or oncogenes: Aberrant expression of microRNAs in head and neck squamous cell carcinoma. Auris Nasus Larynx 40: 143-149, 2013.
5. Ma D, Zhang YY, Guo YL, Li ZJ and Geng L: Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer. Chin Med J (Engl) 125: 4270-4276, 2012.
6. Latchman DS: Transcription factors: An overview. Int J Exp Pathol 74: 417-422, 1993.
7. Libermann TA and Zerbini LF: Targeting transcription factors for cancer gene therapy. Curr Gene Ther 6: 17-33, 2006.
8. Chaudhry P, Srinivasan R and Patel FD: Differential expression of Fas family members and Bcl-2 family members in benign versus malignant epithelial ovarian cancer (EOC) in North Indian population. Mol Cell Biochem 368: 119-126, 2012.
9. Abdel-Rahman WM, Ruosaari S, Knuutila S and Peltomäki P: Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma. World J Gastroenterol 18: 3896-3903, 2012.
10. Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res 14: 1902-1910, 2004.
11. Baskerville S and Bartel DP: Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11: 241-247, 2005.
12. Cao G, Huang B, Liu Z, Zhang J, Xu H, Xia W, et al: Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem Biophys Res Commun 396: 978-982, 2010.
13. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, et al: Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29, 2010.
14. Das Ghosh D, Bhattacharjee B, Sen S, Premi L, Mukhopadhyay I, et al: Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions. PLoS One 7: e44678, 2012.
15. Sethupathy P, Corda B and Hatzigeorgiou AG: TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 12: 192-197, 2006.
16. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, et al: miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-D169, 2011.
17. Wang J, Lu M, Qiu C and Cui Q: TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res 38: D119-D122, 2010.
18. Kozomara A and Griffiths-Jones S: miRBase integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-D157, 2011.
19. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, et al: miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37: D98-D104, 2009.
20. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27: 29-34, 1999.
21. Safran M, Dalah I, Alexander J, et al: GeneCards Version 3: the human gene integrator. Database (Oxford) 5: 2010, 2010.
22. Chekmenev DS, Haid C and Kel AE: P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res 33: W432-W437, 2005.
23. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, et al: The UCSC genome browser database: update 2011. Nucleic Acids Res 39: D876-D882, 2011.
24. Lu TX, Lim EJ, Itskovich S, Besse JA, Plassard AJ, et al: Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. PLoS One 8: e59397, 2013.
25. Muppala S, Mudduluru G, Leupold JH, Buergy D, Sleeman JP and Allgayer H: CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a. PLoS One 8: e59563, 2013.
26. Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, et al; French Cowden Disease Network: High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 50: 255-263, 2013.
27. Wang F, Liu M, Li X and Tang H: MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett 587: 488-495, 2013.
28. Hou LL, Gao C, Chen L, Hu GQ and Xie SQ: Essential role of autophagy in fucoxanthin-induced cytotoxicity to human epithelial cervical cancer HeLa cells. Acta Pharmacologica Sinica 34: 1403-1410, 2013.
29. Lui WO, Pourmand N, Patterson BK and Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043, 2007.
30. Yang ZZ, Chen S, Luan X, Li YX, Liu M, Li X, Liu T and Tang H: MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 61: 1075-1082, 2009.
31. Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L and Benchimol S: Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J 3: 3257-3262, 1984.
32. Fukazawa T, Maeda Y, Matsuoka J, Yamatsuji T, Shigemitsu K, et al: Inhibition of Myc effectively targets KRAS mutation-positive lung cancer expressing high levels of Myc. Anticancer Res 30: 4193-4200, 2010.
33. Wu X, Ajani JA, Gu J, Chang DW, Tan W, et al: MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila) 6: 196-205, 2013.
34. Yamazaki H, Chijiwa T, Inoue Y, Abe Y, Suemizu H, et al: Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med 3: 793-796, 2012.